Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

abstract

About 40% of the cancer burden in high income countries can be explained by known risk factors, although international differences in incidence point to other unknown causes.  Several established carcinogens leave specific mutation patterns in the cancer genome, ie mutational signatures.  This suggests that sequencing large numbers of tumour samples from different populations may be a useful strategy to identify novel causes of cancer.